Notice of Privacy Practices
Salve Care PLLC Notice of Privacy Practices (DBA: BloomNow, Bloom)
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
I. Who We Are
This Notice of Privacy Practices (“Notice”) describes the privacy practices of Salve Care PLLC and its affiliates, including certain affiliated professional entities and their physicians, health care practitioners, and other personnel (“we” or “us”).
II. Our Privacy Obligations
We are required by law to maintain the privacy of your health information (“Protected Health Information” or “PHI”) and to provide you with this Notice of our legal duties and privacy practices with respect to your PHI. We are also obligated to notify you following a breach of unsecured PHI. When we use or disclose your PHI, we are required to abide by the terms of this Notice (or other notice in effect at the time of the use or disclosure).
III. Permissible Uses and Disclosures Without Your Written Authorization
We do not need any type of authorization for the following uses and disclosures:
- For Treatment, Payment, and Health Care Operations: We may use and disclose PHI to provide you with treatment, obtain payment for services, and conduct our health care operations.
- Disclosure to Relatives, Close Friends, and Other Caregivers: We may disclose your PHI to people involved in your care or payment for your care based on your agreement, opportunity to object, or our professional judgment.
- Public Health Activities: We may disclose your PHI for certain public health activities.
- Victims of Abuse, Neglect, or Domestic Violence: We may disclose your PHI to appropriate authorities if we believe you are a victim of abuse, neglect, or domestic violence.
- Health Oversight Activities: We may disclose your PHI to health oversight agencies.
- Judicial and Administrative Proceedings: We may disclose your PHI in legal proceedings.
- Law Enforcement Officers: We may disclose your PHI to law enforcement officials as required or permitted by law.
- Decedents: We may disclose your PHI to coroners, medical examiners, or funeral directors.
- Research: We may use or disclose your PHI for research with proper oversight.
- Health or Safety: We may use or disclose your PHI to prevent a serious threat to health or safety.
- Specialized Government Functions: We may disclose your PHI for specialized government functions.
- Workers’ Compensation: We may disclose your PHI for workers’ compensation purposes.
- As Required By Law: We may use and disclose your PHI when required by law.
IV. Uses and Disclosures Requiring Your Written Authorization
- Use or Disclosure with Your Authorization: For uses and disclosures beyond treatment, payment, and health care operations, we require your written authorization.
- Uses and Disclosures of Your Highly Confidential Information: We require your written authorization to use or disclose highly confidential information.
V. Your Rights Regarding Your Protected Health Information
You have rights regarding your PHI, including the rights to access and copy your health information, request amendments, receive an accounting of disclosures, and receive a copy of this Notice.
VI. Effective Date and Duration of This Notice
- Effective Date: This Notice is effective on [Date].
- Right to Change Terms of this Notice: We may change the terms of this Notice at any time. The new notice will be effective for all PHI we maintain.
VII. Privacy Officer
For more information about our privacy practices, or to file a complaint, please contact:
Email: privacy@bloomhealth.com
Medication Information Please carefully review the important FDA warnings linked below regarding medications you may be prescribed. If you have any questions or concerns, it’s crucial to consult with your healthcare provider or a licensed medical professional.
Note: A significant portion of the medications prescribed through Bloom Health are compounded, formulated specifically to meet individual patient needs. These medications are prepared in pharmacies that are not only licensed in the USA but also have a long-standing history of providing high-quality compounded medications. We ensure that we partner exclusively with these reputable pharmacies to guarantee the safety and efficacy of the compounded medications we offer. It’s important to have a discussion with your healthcare provider about the specific risks and benefits associated with the use of compounded medications. The safety information provided here is intended for your convenience and should not replace professional medical advice regarding the safety and effectiveness of any compounded medications.
Medication Information
We urge you to carefully review the information provided through the links below. This information includes critical warnings from the FDA regarding medications that may be prescribed to you as part of your treatment plan with Salve Care PLLC (Bloom, BloomNow). Should you have any inquiries or require further clarification, we strongly encourage you to consult with your healthcare provider or reach out to a qualified healthcare professional.
It’s important to note that the majority of medications prescribed by Salve Care PLLC (Bloom, BloomNow) are compounded. Compounded medications are uniquely prepared in pharmacies that hold the requisite licenses, tailored to meet the specific needs of patients. However, it’s essential to understand that the effectiveness and safety profiles of these compounded medications are not directly comparable with those of commercially available drugs. We advise having a detailed discussion with your healthcare provider regarding the potential risks and benefits associated with the use of any compounded medication. The safety data list provided here is intended for your convenience and should not be the sole basis for assessing the safety and efficacy of any compounded medication.
Medical Weight Management Medications
Semaglutide (Active Pharmaceutical Ingredient in Wegovy®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
Tirzepatide (Active Pharmaceutical Ingredient in Mounjaro®)
Please see: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
Phentermine (Active Pharmaceutical Ingredient in Adipex-P®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/085128s065lbl.pdf
Phentermine + Topiramate (Active Pharmaceutical Ingredient in Qsymia®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022580s000lbl.pdf
Naltrexone + Bupropion (Active Pharmaceutical Ingredient in Contrave®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/200063s000lbl.pdf
Liraglutide (Active Pharmaceutical Ingredient in Saxenda®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206321orig1s000lbl.pdf
Hormone Replacement Therapy Medications
Testosterone Cypionate (Active Pharmaceutical Ingredient in Depo® -Testosterone)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s040lbl.pdf
Anastrozole (Active Pharmaceutical Ingredient in Arimidex®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf
Clomiphene Citrate (Active Pharmaceutical Ingredient in Clomid®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf
Insomnia Medications
Hydroxyzine Pamoate (Active Pharmaceutical Ingredient in Vistaril®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022411s008lbl.pdf
Trazadone (Active Pharmaceutical Ingredient in Oleptro®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020541s026lbl.pdf
Mirtazapine (Active Pharmaceutical Ingredient in Remeron®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020415s023s024.pdf
Zolpidem (Active Pharmaceutical Ingredient in Ambien®)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019908s027lbl.pdf
Miscellaneous Medications
Cyanocobalamin (Vitamin B12)
Please See: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/080737Orig1s040lbl.pdf